Theory Financial »

Fate Therapeutics shares owned by Theory Financial

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Theory Financial from 13F filings

Historical chart of Theory Financial investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Theory Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Theory Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $60k 22k 2.70

More positions owned by Theory Financial

Schwab Strategic Tr Us Aggregate B (SCHZ)
Select Sector Spdr Tr St Str Svc Etf (XLC)
Spdr Series Trust St Str P500etf (SPYM)
Ishares Tr Mbs Etf (MBB)
Dbx Etf Tr Xtrack Usd High (HYLB)
Simplify Exchange Traded Fun Managed Futures (CTA)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Wisdomtree Tr Us Midcap Fund (EZM)
Etf Opportunities Trust Smi Full Etf (FCTE)
Ishares Tr Ishares Semicdtr (SOXX)
Tidal Trust I Fund Gran Us Etf (GRNY)
Ishares Msci Gbl Etf New (PICK)
Ishares Tr Core Univrsl Usd (IUSB)
Invesco Exchange Traded Fd T Dorsey Wrgt Tech (PTF)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Theory Financial

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Acadian Asset Management
AQR Capital Management
Two Sigma Investments
Johnson & Johnson
Renaissance Technologies
Millennium Management
State Street Corporation
Goldman Sachs Group
Geode Capital Management
Jane Street
Citadel Advisors

View all funds holding Fate Therapeutics